Through competitive binding to circSOD2, miR-532-3p can promote the expression of PAX5 and the progression of ccRCC, and such regulation can be salvaged by miR-532-3p inhibitor. This evidence concerns the gene PAX5 and nonpapillary renal cell carcinoma.